Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo aims to ease pain in newborn surgery

NCT ID NCT07609836

First seen May 29, 2026 · Last updated Jun 23, 2026 · Updated 5 times

Summary

This study tests whether adding dexamethasone to the standard painkiller bupivacaine improves pain relief for newborns undergoing inguinal hernia repair. 150 full-term infants will be randomly assigned to receive either the combination or bupivacaine alone via a caudal injection. Pain will be measured using the FLACC scale for 24 hours after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WE ARE STUDYING THE EFFECTS OF CAUDAL DEXAMETHASONE IN NEONATES UNDERGOING INGUINAL HERNIA REPAIR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dexamethasone added to bupivacaine

What this could lead to

If it works, this could provide better pain control for newborns after hernia surgery, reducing their discomfort.

What could go wrong

This is a small, early-stage study with no phase assigned. The added dexamethasone may not improve pain relief and could carry risks like infection or delayed healing.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.